Ping An Healthcare and Technology Company Limited

SEHK:1833 Voorraadrapport

Marktkapitalisatie: HK$7.2b

Ping An Healthcare and Technology Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Ping An Healthcare and Technology heeft een totaal eigen vermogen van CN¥13.4B en een totale schuld van CN¥10.5M, wat de schuld-eigenvermogensverhouding op 0.08% brengt. De totale activa en totale passiva bedragen respectievelijk CN¥16.2B en CN¥2.8B.

Belangrijke informatie

0.08%

Verhouding schuld/eigen vermogen

CN¥10.50m

Schuld

Rente dekkingsration/a
ContantCN¥11.23b
AandelenCN¥13.37b
Totaal verplichtingenCN¥2.83b
Totaal activaCN¥16.20b

Recente financiële gezondheidsupdates

Recent updates

Ping An Healthcare and Technology Company Limited (HKG:1833) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Nov 17
Ping An Healthcare and Technology Company Limited (HKG:1833) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Ping An Healthcare and Technology Company Limited (HKG:1833) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected

Sep 27
Ping An Healthcare and Technology Company Limited (HKG:1833) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected

Ping An Healthcare and Technology Company Limited (HKG:1833) Shares Could Be 49% Below Their Intrinsic Value Estimate

Sep 20
Ping An Healthcare and Technology Company Limited (HKG:1833) Shares Could Be 49% Below Their Intrinsic Value Estimate

Ping An Healthcare and Technology Company Limited's (HKG:1833) Share Price Not Quite Adding Up

Jul 17
Ping An Healthcare and Technology Company Limited's (HKG:1833) Share Price Not Quite Adding Up

Revenues Not Telling The Story For Ping An Healthcare and Technology Company Limited (HKG:1833)

Apr 17
Revenues Not Telling The Story For Ping An Healthcare and Technology Company Limited (HKG:1833)

Ping An Healthcare and Technology (HKG:1833) Is In A Strong Position To Grow Its Business

Mar 20
Ping An Healthcare and Technology (HKG:1833) Is In A Strong Position To Grow Its Business

Calculating The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

Jan 12
Calculating The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

Getting In Cheap On Ping An Healthcare and Technology Company Limited (HKG:1833) Is Unlikely

Dec 22
Getting In Cheap On Ping An Healthcare and Technology Company Limited (HKG:1833) Is Unlikely

We're Hopeful That Ping An Healthcare and Technology (HKG:1833) Will Use Its Cash Wisely

Sep 27
We're Hopeful That Ping An Healthcare and Technology (HKG:1833) Will Use Its Cash Wisely

A Look At The Intrinsic Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

Sep 10
A Look At The Intrinsic Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

When Should You Buy Ping An Healthcare and Technology Company Limited (HKG:1833)?

Aug 02
When Should You Buy Ping An Healthcare and Technology Company Limited (HKG:1833)?

Here's Why We're Not Too Worried About Ping An Healthcare and Technology's (HKG:1833) Cash Burn Situation

Jun 26
Here's Why We're Not Too Worried About Ping An Healthcare and Technology's (HKG:1833) Cash Burn Situation

Ping An Healthcare and Technology Company Limited's (HKG:1833) Share Price Could Signal Some Risk

Jun 07
Ping An Healthcare and Technology Company Limited's (HKG:1833) Share Price Could Signal Some Risk

Is There An Opportunity With Ping An Healthcare and Technology Company Limited's (HKG:1833) 46% Undervaluation?

Apr 04
Is There An Opportunity With Ping An Healthcare and Technology Company Limited's (HKG:1833) 46% Undervaluation?

Should You Think About Buying Ping An Healthcare and Technology Company Limited (HKG:1833) Now?

Feb 16
Should You Think About Buying Ping An Healthcare and Technology Company Limited (HKG:1833) Now?

We Think Ping An Healthcare and Technology (HKG:1833) Can Afford To Drive Business Growth

Jan 23
We Think Ping An Healthcare and Technology (HKG:1833) Can Afford To Drive Business Growth

A Look At The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

Jan 02
A Look At The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth

Oct 11
Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth

Estimating The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

Sep 14
Estimating The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth

Jun 22
Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth

We're Hopeful That Ping An Healthcare and Technology (HKG:1833) Will Use Its Cash Wisely

Mar 01
We're Hopeful That Ping An Healthcare and Technology (HKG:1833) Will Use Its Cash Wisely

We're Not Very Worried About Ping An Healthcare and Technology's (HKG:1833) Cash Burn Rate

Nov 13
We're Not Very Worried About Ping An Healthcare and Technology's (HKG:1833) Cash Burn Rate

Are Ping An Healthcare and Technology Company Limited (HKG:1833) Investors Paying Above The Intrinsic Value?

Oct 18
Are Ping An Healthcare and Technology Company Limited (HKG:1833) Investors Paying Above The Intrinsic Value?

Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth

Aug 05
Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth

Are Ping An Healthcare and Technology Company Limited (HKG:1833) Investors Paying Above The Intrinsic Value?

Jul 10
Are Ping An Healthcare and Technology Company Limited (HKG:1833) Investors Paying Above The Intrinsic Value?

We Think Ping An Healthcare and Technology (HKG:1833) Can Afford To Drive Business Growth

Apr 04
We Think Ping An Healthcare and Technology (HKG:1833) Can Afford To Drive Business Growth

If You Had Bought Ping An Healthcare and Technology (HKG:1833) Shares A Year Ago You'd Have Earned 47% Returns

Feb 28
If You Had Bought Ping An Healthcare and Technology (HKG:1833) Shares A Year Ago You'd Have Earned 47% Returns

Are Institutions Heavily Invested In Ping An Healthcare and Technology Company Limited's (HKG:1833) Shares?

Jan 24
Are Institutions Heavily Invested In Ping An Healthcare and Technology Company Limited's (HKG:1833) Shares?

We Think Ping An Healthcare and Technology (HKG:1833) Can Easily Afford To Drive Business Growth

Dec 29
We Think Ping An Healthcare and Technology (HKG:1833) Can Easily Afford To Drive Business Growth

Does This Valuation Of Ping An Healthcare and Technology Company Limited (HKG:1833) Imply Investors Are Overpaying?

Dec 03
Does This Valuation Of Ping An Healthcare and Technology Company Limited (HKG:1833) Imply Investors Are Overpaying?

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( CN¥12.8B ) 1833 } overtreffen de korte termijn passiva ( CN¥2.7B ).

Langlopende schulden: De kortetermijnactiva 1833 ( CN¥12.8B ) overtreffen de langetermijnschulden ( CN¥126.0M ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 1833 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van 1833 is de afgelopen 5 jaar gestegen van 0% naar 0.08%.


Balans


Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: 1833 heeft op basis van de huidige vrije kasstroom voldoende cash runway voor meer dan 3 jaar.

Voorspelling contante baan: Er zijn onvoldoende gegevens om te bepalen of 1833 voldoende cash runway heeft als de vrije kasstroom blijft groeien of krimpen op basis van historische percentages.


Ontdek gezonde bedrijven

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2024/12/20 05:26
Aandelenkoers aan het einde van de dag2024/12/20 00:00
Inkomsten2024/06/30
Jaarlijkse inkomsten2023/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige regelgevingsformulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Lees hier meer.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren, zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen voor het gebruik van onze rapporten en tutorials op Youtube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op .

Bronnen van analisten

Ping An Healthcare and Technology Company Limited wordt gevolgd door 25 analisten. 13 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Xiaomeng ZhuangBofA Global Research
Shun Kei LawCCB International Securities Limited
Hazim BahariCFRA Equity Research